Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

OUR NETWORK OF COMPANIES. At Medical Knowledge Group, you won’t just accept a job. You’ll gain a career.

News

Blog 25 days ago
Protected: Medical Knowledge Group
Medical Knowledge Group partners with biopharma innovators on brand strategy, medical communications, analytics, market access, and commercialization.
Read more
Report
Press release PRNewswire 7 months ago
Medical Knowledge Group Appoints David Margines to Board of Directors, Advancing Its Legacy in AI- and Analytics-Driven Drug Commercialization
/PRNewswire/ -- Medical Knowledge Group (MKG) today announced the appointment of David Margines to its Board of Directors. The move deepens the company
Read more
Report
Blog 1 year ago
Terms of Use
Terms of Use Effective Date: July 28, 2025 Welcome to the website (
Read more
Report
Blog 1 year ago
Code of Conduct
MKG Code of Conduct Overview This Code of Conduct (Code) provides an overview of our commitment to ethical business practices, and it applies universally to all employees, regardless of their employment status (full-time or part-time) or their location wi
Read more
Report
Blog 1 year ago
Impact Statement
Medical Knowledge Group (MKG) of Companies ESG Impact Statement Through its subsidiaries, MKG addresses the business needs of biopharmaceutical companies through the provision of proprietary analytics and multi-channel marketing solutions. Our companies a
Read more
Report
News PE Hub 6 years ago
Court Square completes recap of WindRose-backed Medical Knowledge Group
WindRose invested in Medical Knowledge Group in August 2017
Read more
Report
Blog 9 years ago
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!The post Hello world! first appeared on Medical Knowledge Group.
Read more
Report
News PE Hub 9 years ago
MTS recaps Medical Knowledge Group
MTS Health Investors LLC has recapitalized New York City-based Medical Knowledge Group, a healthcare marketing and communications provider for the biopharmaceutical industry. No financial terms were disclosed.
Read more
Report